Maze Therapeutics, Inc. · NASDAQ:MAZE

Coloma Jason V sold 34,501 Maze Therapeutics, Inc. shares (Form 4)

Traded Aug 3, 2026 · Filed Aug 5, 2026

On Aug 3, 2026, Coloma Jason V (Director, Chief Executive Officer) sold 34,501 Maze Therapeutics, Inc. shares at an average US$26.73 for US$922K under a trading plan, leaving 255,263 shares. Filed Aug 5, 2026 (Form 4).

Sold: 34,501 shares
Price: US$26.73 average (US$26.71 to US$27.09)
Value: US$922K
Holding after: 255,263 shares (held indirectly)
Trading plan: Yes (Made under a plan set in advance)
Role: Director, Chief Executive Officer

The filing in full

Date	Security	Transaction	Shares	Price	Holding after	Ownership
Aug 3, 2026	Common Stock	Sale	2,439	US$26.71	20,898	Indirect
Aug 3, 2026	Common Stock	Sale	154	US$27.09	20,744	Indirect
Aug 3, 2026	Common Stock	Sale	30,304	US$26.71	256,867	Indirect
Aug 3, 2026	Common Stock	Sale	1,604	US$27.09	255,263	Indirect

Source

View original at SEC

Related